An approach to the management of infants with impaired haemostasis.
Andrew
M
M
D001327:Autoimmune Diseases / Q000151:congenital; D001778:Blood Coagulation Disorders / Q000151:congenital / Q000628:therapy*; D001792:Blood Platelets / Q000502:physiology; D002543:Cerebral Hemorrhage / Q000628:therapy; D004211:Disseminated Intravascular Coagulation / Q000175:diagnosis / Q000628:therapy; D004730:Endothelium, Vascular / Q000502:physiology; D006487:Hemostasis / Q000502:physiology; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007223:Infant; D007231:Infant, Newborn / Q000097:blood; D007234:Infant, Premature / Q000097:blood; D007235:Infant, Premature, Diseases / Q000097:blood; D012016:Reference Values; D013921:Thrombocytopenia / Q000151:congenital / Q000276:immunology / Q000628:therapy; D013923:Thromboembolism / Q000209:etiology / Q000628:therapy; D014813:Vitamin K Deficiency / Q000175:diagnosis / Q000628:therapy